Emerging metabolic regulators such as fibroblast growth factor 21 (FGF21), other FGFs and myonectin appear to play roles in obesity and insulin resistance, from our experience. Here, C1QTNF5 is linked to obesity due to melanocortin 4 receptor deficiency.